FDA-Drug2020-02-19Class II
Kushim Tablets (Gushim) 45-count packages, Label in foreign language
B AND A TRADING CORPORATION
Hazard
Marketed Without an Approved NDA/ANDA. FDA analysis found product to contain cinobufagin, bufalin, and bufotenine
Sold states
NY & NJ only
Affected count
40 packages
Manufactured in
325 Washington Ave, Carlstadt, NJ, United States
Products
Kushim Tablets (Gushim) 45-count packages, Label in foreign language
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0840-2020Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief